Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.

This publication has 19 references indexed in Scilit:

• Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene
  Cancer Letters, 1997
• Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice
  Cancer Letters, 1995
• Id proteins control growth induction in mammalian cells.
  Proceedings of the National Academy of Sciences, 1994
• Activation of Helix-Loop-Helix Proteins Id1, Id2 and Id3 during Neural Differentiation
  Biochemical and Biophysical Research Communications, 1994
• CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest.
  Genes & Development, 1994
• Isolation, characterization and chromosomal localization of the human GADD153 gene
  Gene, 1992
• CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.
  Genes & Development, 1992
• IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation
  Cell, 1991
• The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
  Published by Elsevier ,1990
• Acute hemodynamic effects of a new inotropic agent (OPC-8212) in patients with congestive heart failure
  Journal of the American College of Cardiology, 1987